Welcome to our dedicated page for Veeva Sys news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Sys stock.
Veeva Systems Inc. reports developments in cloud software, data, AI, and consulting for the life sciences industry. Company news commonly covers adoption of the Veeva Vault Platform, including Development Cloud, Quality Cloud, Commercial Cloud, Data Cloud, Vault CRM, and Veeva MedTech applications for clinical, regulatory, quality, commercial, and medical operations.
Updates also include customer standardization projects with pharmaceutical, biotechnology, medical device, and diagnostics companies; product and data offerings such as Link Key People and Veeva AI; fiscal results and subscription revenue trends; and corporate actions such as acquisitions, including the completed purchase of Ostro as a life sciences brand engagement platform.
Veeva Systems (NYSE: VEEV) announced Veeva EHS, a new environmental, health, and safety application within Veeva Quality Cloud. The solution aims to help manufacturing and testing sites identify, manage, and mitigate operational and environmental risks while supporting global compliance readiness.
Veeva EHS connects with Veeva QMS and Veeva Training so safety events can automatically trigger quality deviations and targeted retraining. The application is designed for real-time incident reporting, end-to-end investigation management, and transparency into leading indicators of risk. Early adopter availability is planned for August 2026.
Veeva Systems (NYSE: VEEV) acquired Copli, a pioneer in agentic medical, legal, and regulatory (MLR) solutions, and launched Veeva Falcon MLR.
The agentic MLR product aims to accelerate content review, with potential to eliminate 70% or more manual MLR labor within five years, supporting marketing teams, MLR groups, and agencies.
Veeva Systems (NYSE: VEEV) announced that biopharma company UCB is unifying its global pharmacovigilance operations on Veeva Safety Suite. UCB will standardize safety case intake, processing, submissions, content management, signal detection, and regulatory data sharing on a single platform to improve efficiency, automation, and global oversight.
Veeva (NYSE: VEEV) reported fiscal 2027 Q1 total revenue of $882.9M, up 16% year over year, with subscription revenue of $730.2M, up 15%.
GAAP net income was $260.9M ($1.57 per diluted share). Veeva updated fiscal 2027 revenue guidance to $3.635–$3.645B and highlighted rapid progress in its Veeva AI, Vault AI, Ostro, and Veeva Falcon initiatives.
Veeva Systems (NYSE: VEEV) announced that global CDMO Kindeva is adopting Veeva Quality Cloud to modernize and unify its worldwide manufacturing quality operations on a single cloud platform.
The deployment includes Veeva QualityDocs, Veeva QMS, Veeva Training, and Veeva LearnGxP, aiming to standardize processes, improve real-time visibility, support regulatory compliance, and enhance operational efficiency across Kindeva’s expanding fill-finish and regional operations.
Veeva Systems (NYSE: VEEV) announced that Teva Pharmaceuticals has committed to deploy Veeva Vault CRM globally. The move expands the companies' strategic partnership and is intended to provide Teva with a technical foundation to support commercial execution and deeper customer engagement.
Vault CRM, part of the Vault CRM Suite, features the Agentic Call Report, which uses compliant free text and commercial evidence to generate insights and support commercial agility.
Veeva Systems (NYSE: VEEV) announced that Merck KGaA, Darmstadt, Germany has committed globally to Veeva Vault CRM as its commercial foundation. Vault CRM and Vault AI for CRM will support data connectivity, consistent processes, customer-centric workflows, and embedded agentic AI across Merck’s worldwide healthcare operations.
Veeva Systems (NYSE: VEEV) announced that Teva Pharmaceuticals has committed to adopt Veeva Vault CRM globally. Vault CRM, part of the Vault CRM Suite, combines agentic CRM and industry-specific AI to support commercial execution and deeper customer engagement, including an Agentic Call Report that uses compliant free text to generate insights.
Veeva Systems (NYSE: VEEV) announced Veeva Falcon, an agentic platform with standard agents for major drug development processes. Falcon works with Veeva Development Cloud clinical, regulatory, and safety applications to help reduce cost, increase speed, and maintain compliance for biopharmas of all sizes.
Initial focus areas include trial master file document intake and quality control, regulatory health authority correspondence, and safety case triage and intake. Falcon is part of Veeva AI and is planned for early adopter availability in November 2026.
Veeva Systems (NYSE: VEEV) will host Veeva Commercial Summit on May 19-20, 2026, in Boston, focused on biopharma AI and agentic commercial.
More than 2,000 life sciences professionals and over 100 sessions will feature leaders from major biopharmas sharing AI-driven commercial, data, CRM, and medical engagement strategies.